Title |
New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31stAnnual Meeting of the Society for Immunotherapy of Cancer, 2016
|
---|---|
Published in |
Journal for Immunotherapy of Cancer, June 2017
|
DOI | 10.1186/s40425-017-0253-2 |
Pubmed ID | |
Authors |
Prasad S. Adusumilli, Edward Cha, Mark Cornfeld, Thomas Davis, Adi Diab, Thomas W. Dubensky, Elizabeth Evans, Jane L. Grogan, Bryan A. Irving, Rom S. Leidner, Shane A. Olwill, Patrick Soon-Shiong, Frederic Triebel, David Tuck, Adrian Bot, Roger D. Dansey, Charles G. Drake, Gordon J. Freeman, Ramy Ibrahim, Salil Patel, Daniel S. Chen |
Abstract |
This report is a summary of 'New Cancer Immunotherapy Agents in Development' program, which took place in association with the 31st Annual Meeting of the Society for Immunotherapy of Cancer (SITC), on November 9, 2016 in National Harbor, Maryland. Presenters gave brief overviews of emerging clinical and pre-clinical immune-based agents and combinations, before participating in an extended panel discussion with multidisciplinary leaders, including members of the FDA, leading academic institutions and industrial drug developers, to consider topics relevant to the future of cancer immunotherapy. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 9 | 53% |
Spain | 1 | 6% |
United Kingdom | 1 | 6% |
Unknown | 6 | 35% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 10 | 59% |
Practitioners (doctors, other healthcare professionals) | 4 | 24% |
Scientists | 2 | 12% |
Science communicators (journalists, bloggers, editors) | 1 | 6% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 40 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 8 | 20% |
Student > Bachelor | 5 | 13% |
Student > Ph. D. Student | 3 | 8% |
Professor > Associate Professor | 3 | 8% |
Professor | 2 | 5% |
Other | 6 | 15% |
Unknown | 13 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Immunology and Microbiology | 7 | 18% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 10% |
Medicine and Dentistry | 4 | 10% |
Agricultural and Biological Sciences | 3 | 8% |
Biochemistry, Genetics and Molecular Biology | 3 | 8% |
Other | 5 | 13% |
Unknown | 14 | 35% |